BioFinlandin jäsen

Marginum is a market forerunner in quantitative surgical techniques developing fluorescence-based tissue monitoring technologies. Data-driven MARGINUM® solutions enable safe and efficient monitoring of tumour tissues during cancer surgery without compromising pre-existent surgical workflows. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’s multidisciplinary team works in close cooperation with academic, clinical, and industrial experts to ensure seamless clinical compatibility of its technological solutions.